DPC Cardiovascular Clinic - Wednesday 30 October 2019

Choose relevant sessions for you in your role:

  • MDT Icon Square

    Multi-disciplinary team – these sessions are suitable for the entire MDT and will aim to promote joint working and understanding of care pathways.

  • PCNS Icon Square

    Primary Care & Non-Specialist – designed for healthcare professionals who are not specialists in diabetes or related conditions, and who may work in a Primary Care setting.

  • SPEC Icon Square

    Specialist – these sessions are designed for specialists in diabetes and related conditions. Sessions may also be appropriate for Primary Care specialists or leads in diabetes and related conditions.

*NB – These are advisory labels so please read the session description and learning outcomes carefully to ensure the session is right for you

10:00 - 10:40

How does diabetes affect my patient’s heart?

People with diabetes are greater risk of cardiovascular problems, including coronary heart disease and heart failure, than those without diabetes. Learning points: Evaluate the impact of diabetes and heart health Recognise lifestyle interventions which can improve cardiovascular outcomes Consider the impact that drug therapies have on heart health, beyond glycaemic control

Beverley Bostock
Education Lead / Clinical Specialist, Education For Health
10:40 - 11:50


11:20 - 11:40

Transforming basal insulin management with JAZZ DoseCoach

The UK’s first basal insulin advisor with integrated blood glucose meter for type 2 patients on once daily basal insulin only, will be available from Autumn 2019. Designed to assist in the self-adjustment of basal insulin dosing, the JAZZ DoseCoach could help tens of thousands of patients who struggle with the complexities of basal insulin…

National Sales Manager, AgaMatrix Europe Ltd.
11:50 - 12:30

CVD risk – micro & macro disease screening & management

Consultant Physician, Diabetes & Endocrinology, County Durham & Darlington Foundation Trust
12:40 - 13:20

DECLARE – 1 year on

DECLARE – 1 year on, will review the recent evidence from the DECLARE and how the information from DECLARE contributes to our overall understanding of the use of SGLT2 inhibitors in clinical practice. In particular the talk will focus on evidence from DECLARE supporting use of dapagliflozin in high risk groups such as those with…

Prof John Wilding
Professor of Medicine & Honorary Consultant Physician, Obesity and Endocrinology Research, Theme Lead for Metabolism and Nutrition, Institute of Ageing & Chronic Disease University Hospital Aintree
13:30 - 14:00

Effective deployment of technology to reduce the pressure on the diabetes team in secondary care

Working with the NHS to facilitate integrated care across combined clinical and patient data. Recognising the importance of software platform flexibility, its ability to scale and accommodate the constantly evolving integrations and care guidelines. Shared security, reporting, audit, interfaces to PAS, Pathology, Document Management and other systems deliver economies of scale and unified ways of…

Product Manager, Clinical Information Systems, Hicom
14:00 - 14:20
14:30 - 14:50

The T2Day Programme LIVE! at Diabetes Professional Care

Sessions sponsored by the Boehringer Ingelheim and Lilly Diabetes Alliance Prescribing and adverse event reporting information is available at: www.jardiancepi.co.uk Join us for T2Day LIVE! with host Dr Amrit Lamba and our expert guests, clinical psychologist, Dr Jen Bateman and obesity expert and GP, Dr Matt Capehorn as they discuss: How to start the discussion…

Clinical Psychologist, London
GPwSI Obesity and Diabetes Management, Rotherham
15:00 - 15:50

Saving Hearts and Minds Together: National CVD Prevention Ambitions

Falling mortality rates from heart disease were the biggest cause of increases in life expectancy between 2001 and 2016 in England. However, since 2011 the rate of increase in life expectancy has slowed for both sexes as improvements in heart disease mortality have plateaued. This highlights the need for a renewed drive to prevent CVD…

Jamie Waterall
National Lead for Cardiovascular Disease Prevention & Deputy Chief Nurse, Priorities and Programmes Division, Public Health England
GP and GPSI Cardiology, President Elect Primary Care Cardiovascular Society
16:00 - 16:40

Panel: MDT CV care

This session will focus on England’s CVD prevention national ambitions, exploring the ABC’s of prevention which were launched by Professor Jamie Waterall earlier this year. Professor Ahmet Fuat will also provide examples best practice, showcasing local innovation and commitment to achieving these 10 year ambitions.  

Beverley Bostock
Education Lead / Clinical Specialist, Education For Health
Consultant Physician, Diabetes & Endocrinology, County Durham & Darlington Foundation Trust
GP and GPSI Cardiology, President Elect Primary Care Cardiovascular Society